These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24588652)

  • 1. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.
    Bäck M; Powell WS; Dahlén SE; Drazen JM; Evans JF; Serhan CN; Shimizu T; Yokomizo T; Rovati GE
    Br J Pharmacol; 2014 Aug; 171(15):3551-74. PubMed ID: 24588652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosanoid receptors as therapeutic targets for asthma.
    Powell WS
    Clin Sci (Lond); 2021 Aug; 135(16):1945-1980. PubMed ID: 34401905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
    Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
    Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of monocytic expression of leukotriene and lipoxin receptors.
    Petri MH; Thul S; Ovchinnikova O; Bäck M
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):138-43. PubMed ID: 26248046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The leukotriene receptors as therapeutic targets of inflammatory diseases.
    Sasaki F; Yokomizo T
    Int Immunol; 2019 Aug; 31(9):607-615. PubMed ID: 31135881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease.
    Pirault J; Bäck M
    Front Pharmacol; 2018; 9():1273. PubMed ID: 30487747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond.
    Sánchez-García S; Jaén RI; Fernández-Velasco M; Delgado C; Boscá L; Prieto P
    Pharmacol Res; 2023 Nov; 197():106982. PubMed ID: 37925045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation.
    McMahon B; Mitchell D; Shattock R; Martin F; Brady HR; Godson C
    FASEB J; 2002 Nov; 16(13):1817-9. PubMed ID: 12223454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
    Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
    J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on leukotrienes and their receptors with reference to asthma.
    Singh RK; Tandon R; Dastidar SG; Ray A
    J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.
    Gagliardo R; Gras D; La Grutta S; Chanez P; Di Sano C; Albano GD; Vachier I; Montalbano AM; Anzalone G; Bonanno A; Riccobono L; Gjomarkaj M; Profita M
    J Allergy Clin Immunol; 2016 Jun; 137(6):1796-1806. PubMed ID: 26971688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvins as new fascinating drug candidates for inflammatory diseases.
    Lee CH
    Arch Pharm Res; 2012 Jan; 35(1):3-7. PubMed ID: 22297737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
    Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
    Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxins and lipoxin analogs in asthma.
    Levy BD
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):231-7. PubMed ID: 16046112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.
    Colby JK; Gott KM; Wilder JA; Levy BD
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):25-33. PubMed ID: 26039320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.
    Powell WS; Rokach J
    Prog Lipid Res; 2013 Oct; 52(4):651-65. PubMed ID: 24056189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosanoids in asthma.
    Wan KS; Wu WF
    Acta Paediatr Taiwan; 2007; 48(6):299-304. PubMed ID: 18437962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.